TABLE 2.
Model 1 (unadjusted) | Model 2 | Model 3 | Model 4 | ||||||
---|---|---|---|---|---|---|---|---|---|
Discussion outcome | Age category | % | Difference (95% CI) | % | Difference (95% CI) | % | Difference (95% CI) | % | Difference (95% CI) |
Health goals | 18–44 | 58.9 | −8.2 (−9.0,‐7.3) | 59.6 | −7.1 (−7.9,‐6.2) | 59.5 | −7.3 (−8.1,‐6.4) | 60.3 | −6.0 (−6.9,‐5.1) |
45–64 | 71.0 | 4.0 (3.7, 4.3) | 71.2 | 4.5 (4.2, 4.9) | 71.1 | 4.3 (4.0, 4.7) | 71.5 | 5.2 (4.8, 5.5) | |
65+ (ref) | 67.0 | 66.7 | 66.8 | 66.3 | |||||
Depression | 18–44 | 82.3 | 8.6 (8.0, 9.3) | 82.2 | 8.4 (7.7, 9.0) | 81.3 | 7.0 (6.3, 7.7) | 81.5 | 7.5 (6.9, 8.2) |
45–64 | 79.2 | 5.5 (5.2, 5.8) | 79.1 | 5.3 (5.0, 5.6) | 79.2 | 4.9 (4.6, 5.2) | 79.3 | 5.3 (5.0, 5.6) | |
65+ (ref) | 73.7 | 73.8 | 74.3 | 74.0 | |||||
Stress | 18–44 | 64.1 | 9.1 (8.3, 9.9) | 63.9 | 8.8 (8.0, 9.7) | 62.5 | 6.8 (5.9, 7.6) | 62.4 | 6.7 (5.8, 7.6) |
45–64 | 63.0 | 8.0 (7.7, 8.4) | 63.0 | 7.9 (7.5, 8.3) | 62.9 | 7.2 (6.8, 7.6) | 63.1 | 7.4 (7.0, 7.7) | |
65+ (ref) | 55.0 | 55.1 | 55.7 | 55.7 | |||||
Personal problems | 18–44 | 58.9 | 13.9 (13.0,14.7) | 59.4 | 14.6 (13.7,15.5) | 58.4 | 13.1 (12.2,14.0) | 57.6 | 12.0 (11.1,12.9) |
45–64 | 57.4 | 12.4 (12.0,12.8) | 57.6 | 12.8 (12.4,13.1) | 57.4 | 12.1 (11.7,12.5) | 57.3 | 11.7 (11.3,12.1) | |
65+ (ref) | 45.0 | 44.8 | 45.3 | 45.6 | |||||
Medications | 18–44 | 43.2 | −8.7 (−9.6,‐7.8) | 43.1 | −8.9 (−9.9,‐8.0) | 43.0 | −9.1 (−10.0,‐8.1) | 44.2 | −7.2 (−8.1,‐6.2) |
45–64 | 50.9 | −1.0 (−1.4,‐0.7) | 50.8 | −1.1 (−1.5,‐0.8) | 51.1 | −1.0 (−1.4,‐0.6) | 51.6 | 0.2 (−0.2, 0.6) | |
65+ (ref) | 51.9 | 52.0 | 52.0 | 51.4 |
Note: Model 1: unadjusted. Model 2: adjusted for sex. Model 3: adjusted for sex, socioeconomic status (SES), education and urbanicity/rurality. Model 4: adjusted for sex, SES, education, urbanicity/rurality, self‐rated health, self‐rated mental health and Gagne comorbidity index. Differences with positive values indicate worse outcomes for the 65+ age group. Differences with negative values indicate better outcomes for the 65+ age group.